申请人:Lundblad, Leif
公开号:EP0231159A1
公开(公告)日:1987-08-05
Novel indoloquinoxalines having substituents in 6- position containing cyclic groups, of the general formula I
wherein R1 represents hydrogen or one or several preferably 1 to 4, similar or different substituents in the positions 1-4 and/or 7-10, selected from halogen, lower alkyl-/alkoxy group having not more than 4 carbon atoms, trifluoromethyl group, trichloromethyl group; X is a group
wherein Y is CH2, NH, O or S and a is 2, 3 or 4 and wherein also the bond -C=N- can be saturated; Z is alkyl having 1-6 carbon atoms, Cl, Br or CF3 and R3 represents hydrogen, lower alkyl-/cykloalkyl group having not more than 4 carbon atoms, and the physiologically acceptable addition products of the compounds with acids and halogen adducts are described. Also methods for preparing said compounds by reaction of a compound of the formula II
with a reactive compound containing the residue -CHR3X or by rearranging a compound of the formula III
by heating, are described.
· The novel indoloquinoxalines have antiviral effect and have effect against cancer.
新型吲哚喹喔啉,其 6-位取代基含有通式 I 的环状基团
其中 R1 代表氢或在 1-4 位和/或 7-10 位上的一个或多个(最好是 1 至 4 个)相似或不同的取代基,选自卤素、不超过 4 个碳原子的低级烷基/烷氧基、三氟甲基、三氯甲基;X 是一个基团
其中 Y 是 CH2、NH、O 或 S,a 是 2、3 或 4,键 -C=N- 也可以是饱和的;Z 是具有 1-6 个碳原子的烷基、Cl、Br 或 CF3,R3 代表氢、具有不超过 4 个碳原子的低级烷基-/环烷基,并描述了这些化合物与酸和卤素加成物的生理学上可接受的加成产物。此外,还描述了通过式 II 的化合物与含有残余物
与含有残基 -CHR3X 的活性化合物反应或通过加热重排式 III 的化合物来制备上述化合物的方法。
通过加热重新排列式 III 的化合物来制备上述化合物的方法。
- 新型吲哚喹喔啉类化合物具有抗病毒和抗癌作用。